Leaders in Research Peptides

(£) GBP (Default)
  • ($) USD
  • (€) EUR
  • ($) AUD
  • ($) CAD
  • ($) NZD
(£) GBP (Default)
  • ($) USD
  • (€) EUR
  • ($) AUD
  • ($) CAD
  • ($) NZD

FOXO4-DRI Nasal Spray

£203.69£402.38

Buy FOXO4-DRI Nasal Spray

FOXO4-DRI is a cell-penetrating peptide that reverses the effects of ageing in animal studies by selectively inducing apoptosis in senescent cells.

FOXO4-DRI 15ml contains: 10mg
FOXO4-DRI 30ml contains: 20mg

Buy 10 and get 10% Discount

Out of stock

Description

FOXO4-DRI Nasal Spray Monaco

This product is intended for research purposes only. To be used by trained professionals only.

FOXO4-DRI is a synthetic peptide that’s been gaining interest due to its potential senolytic properties, which means it has the ability to selectively induce death of senescent cells. Senescent cells are essentially aged or damaged cells that have lost their capacity to divide but remain metabolically active. They contribute to aging and age-related diseases, including hair loss..

The peptide works by disrupting the interaction between two proteins: FOXO4 and p53. Under normal conditions, FOXO4 interacts with p53 to prevent it from causing cell death, thereby allowing senescent cells to persist. However, when FOXO4-DRI is introduced, it competes with FOXO4 for binding to p53, effectively freeing up p53 to induce cell death in senescent cells [1].

In the context of age-related diseases, FOXO4-DRI’s senolytic action could potentially be harnessed to counteract conditions such as hair loss. Hair follicles, like all tissues, contain a population of stem cells that divide and differentiate to regenerate the tissue. However, as we age, these stem cells can become senescent and lose their regenerative capabilities, leading to hair thinning and eventual hair loss.

One Monaco study published investigated the effect of FOXO4-DRI nasal spray on bleomycin-induced pulmonary fibrosis in mice, showing that it could clear senescent cells and reverse the disease [2]. This suggests that similar mechanisms might be at play in other tissues affected by senescence, such as hair follicles.

While no direct studies have yet demonstrated the effects of FOXO4-DRI on hair loss, the peptide’s ability to eliminate senescent cells makes it a promising candidate for future research in this area. Further studies are needed to fully understand and confirm the potential benefits of FOXO4-DRI nasal spray for hair loss.


References:

[1] https://pubmed.ncbi.nlm.nih.gov/ 33996787/

[2] https://onlinelibrary.wiley.com/doi/ full/10.1111/jcmm.17333

FOXO4-DRI HPLC 2023 Certificates_DIRECT PEPTIDES

 

 

 

 

 

 

 

 


ALL CONTENT AND PRODUCT INFORMATION AVAILABLE ON THIS WEBSITE IS FOR EDUCATIONAL PURPOSES ONLY.

DISCLAIMER: These products are intended solely as a research chemical only. This classification allows for their use only for research development and laboratory studies. The information available on our Monaco Direct Peptides website: https://monaco.direct-peptides.com is provided for educational purposes only. These products are not for human or animal use or consumption in any manner. Handling of these products should be limited to suitably qualified professionals. They are not to be classified as a drug, food, cosmetic, or medicinal product and must not be mislabelled or used as such.


BUY FOXO4-DRI Nasal Spray ONLINE today From Monaco Direct Peptides